Centessa is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and blood disorders.
Business Model:
Revenue: $69.5B
Employees: 51-200
Address: 1 Ashley Road
City: Cheshire
State: england
Zip: WA14 2DT
Country: GB
Centessa is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and blood disorders.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/27/2021
IPO Valuation:
$2B
Ticker Symbol:
CNTA
IPO Price:
$20/share
Amount Raised:
$330M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2021 | IPO | $330M |
|
2/2021 | Series A | 14 | $250M |
Franklin Templeton Investments Logos Capital Venrock Healthcare Capital Partners BVF Partners Cormorant Asset Management Boxer Capital Wellington Management Vida Ventures T. Rowe Price General Atlantic Janus Henderson Investors Vida Ventures Samsara BioCapital LifeSci Venture Partners Franklin Templeton Investments Logos Capital Venrock Healthcare Capital Partners BVF Partners Cormorant Asset Management Boxer Capital Wellington Management Vida Ventures T. Rowe Price General Atlantic Janus Henderson Investors Vida Ventures |
10/2021 | Post-IPO Debt | $0 |
Oberland Capital Oberland Capital |
10/2021 | Post-IPO Debt | 1 | $300M |
Oberland Capital Management LLC Oberland Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|